328 related articles for article (PubMed ID: 26994951)
1. Systemic and cell-specific mechanisms of vasculopathy induced by human immunodeficiency virus and highly active antiretroviral therapy.
Haser GC; Sumpio B
J Vasc Surg; 2017 Mar; 65(3):849-859. PubMed ID: 26994951
[TBL] [Abstract][Full Text] [Related]
2. Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus.
Beltrán LM; Rubio-Navarro A; Amaro-Villalobos JM; Egido J; García-Puig J; Moreno JA
Vasc Health Risk Manag; 2015; 11():35-48. PubMed ID: 25609975
[TBL] [Abstract][Full Text] [Related]
3. [HIV infection, antiretroviral therapy, and endothelium].
Hürlimann D; Weber R; Enseleit F; Lüscher TF
Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
[TBL] [Abstract][Full Text] [Related]
4. [Metabolic and cardiovascular effects of combined antiretroviral therapy in patients with HIV infection. Systematic review of literature].
Casaretti L; Paolillo S; Formisano R; Bologna A; Mattiello G; Conte S; Petraglia L; Lo ludice F; Fabiani I; Cirillo AP; Vitagliano A; Gambardella F; della Ratta GL; Filardi PP
Monaldi Arch Chest Dis; 2011 Dec; 76(4):175-82. PubMed ID: 22567733
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular implications of HIV-induced dyslipidemia.
Giannarelli C; Klein RS; Badimon JJ
Atherosclerosis; 2011 Dec; 219(2):384-9. PubMed ID: 21722900
[TBL] [Abstract][Full Text] [Related]
6. Endothelial and platelet function alterations in HIV-infected patients.
Gresele P; Falcinelli E; Sebastiano M; Baldelli F
Thromb Res; 2012 Mar; 129(3):301-8. PubMed ID: 22192157
[TBL] [Abstract][Full Text] [Related]
7. Highly active antiretroviral therapy-related mechanisms of endothelial and platelet function alterations.
Gresele P; Falcinelli E; Momi S; Francisci D; Baldelli F
Rev Cardiovasc Med; 2014; 15 Suppl 1():S9-20. PubMed ID: 24987863
[TBL] [Abstract][Full Text] [Related]
8. Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy.
Calza L; Manfredi R; Pocaterra D; Chiodo F
J Infect; 2008 Jul; 57(1):16-32. PubMed ID: 18358535
[TBL] [Abstract][Full Text] [Related]
9. Highly active antiretroviral therapy-associated metabolic syndrome and cardiovascular risk.
Barbaro G; Barbarini G
Chemotherapy; 2006; 52(4):161-5. PubMed ID: 16675900
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular manifestations of HIV infection in children.
Idris NS; Grobbee DE; Burgner D; Cheung MM; Kurniati N; Sastroasmoro S; Uiterwaal CS
Eur J Prev Cardiol; 2015 Nov; 22(11):1452-61. PubMed ID: 25398702
[TBL] [Abstract][Full Text] [Related]
11. Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection.
Barbaro G
Curr HIV Res; 2006 Jan; 4(1):79-85. PubMed ID: 16454713
[TBL] [Abstract][Full Text] [Related]
12. Determinants of endothelial function in human immunodeficiency virus infection: a complex interplay among therapy, disease, and host factors.
Mondy KE
J Cardiometab Syndr; 2008; 3(2):88-92. PubMed ID: 18453808
[TBL] [Abstract][Full Text] [Related]
13. HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults.
Lipshultz SE; Mas CM; Henkel JM; Franco VI; Fisher SD; Miller TL
Expert Rev Anti Infect Ther; 2012 Jun; 10(6):661-74. PubMed ID: 22734956
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease.
Anuurad E; Semrad A; Berglund L
Metab Syndr Relat Disord; 2009 Oct; 7(5):401-10. PubMed ID: 19355810
[TBL] [Abstract][Full Text] [Related]
15. Highly active antiretroviral therapy and the cardiovascular system: the heart of the matter.
Barbaro G
Pharmacology; 2003 Dec; 69(4):177-9. PubMed ID: 14624056
[TBL] [Abstract][Full Text] [Related]
16. Dyslipidemia and cardiovascular risk in human immunodeficiency virus infection.
Kelesidis T; Currier JS
Endocrinol Metab Clin North Am; 2014 Sep; 43(3):665-84. PubMed ID: 25169560
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disease in patients with HIV.
Ballocca F; D'Ascenzo F; Gili S; Grosso Marra W; Gaita F
Trends Cardiovasc Med; 2017 Nov; 27(8):558-563. PubMed ID: 28779949
[TBL] [Abstract][Full Text] [Related]
18. Etiology and pharmacologic management of noninfectious diarrhea in HIV-infected individuals in the highly active antiretroviral therapy era.
MacArthur RD; DuPont HL
Clin Infect Dis; 2012 Sep; 55(6):860-7. PubMed ID: 22700829
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral therapy with heart.
Randell P; Moyle G
Am J Ther; 2009; 16(6):579-84. PubMed ID: 19940610
[TBL] [Abstract][Full Text] [Related]
20. The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction.
Kline ER; Sutliff RL
J Investig Med; 2008 Jun; 56(5):752-69. PubMed ID: 18525451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
